FDA Inspection 1110441 — Wacker Biotech GmbH
The FDA completed an inspection of Wacker Biotech GmbH on September 6, 2019 in Halle (Saale). The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- September 6, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Halle (Saale) (Germany)